Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

96 results about "Chest radiograph" patented technology

A chest radiograph, colloquially called a chest X-ray (CXR), or chest film, is a projection radiograph of the chest used to diagnose conditions affecting the chest, its contents, and nearby structures. Chest radiographs are the most common film taken in medicine.

Image modification and detection using massive training artificial neural networks (MTANN)

A method, system, and computer program product for modifying an appearance of an anatomical structure in a medical image, e.g., rib suppression in a chest radiograph. The method includes: acquiring, using a first imaging modality, a first medical image that includes the anatomical structure; applying the first medical image to a trained image processing device to obtain a second medical image, corresponding to the first medical image, in which the appearance of the anatomical structure is modified; and outputting the second medical image. Further, the image processing device is trained using plural teacher images obtained from a second imaging modality that is different from the first imaging modality. In one embodiment, the method also includes processing the first medical image to obtain plural processed images, wherein each of the plural processed images has a corresponding image resolution; applying the plural processed images to respective multi-training artificial neural networks (MTANNs) to obtain plural output images, wherein each MTANN is trained to detect the anatomical structure at one of the corresponding image resolutions; and combining the plural output images to obtain a second medical image in which the appearance of the anatomical structure is enhanced.
Owner:UNIVERSITY OF CHICAGO

Image modification and detection using massive training artificial neural networks (MTANN)

A method, system, and computer program product for modifying an appearance of an anatomical structure in a medical image, e.g., rib suppression in a chest radiograph. The method includes: acquiring, using a first imaging modality, a first medical image that includes the anatomical structure; applying the first medical image to a trained image processing device to obtain a second medical image, corresponding to the first medical image, in which the appearance of the anatomical structure is modified; and outputting the second medical image. Further, the image processing device is trained using plural teacher images obtained from a second imaging modality that is different from the first imaging modality. In one embodiment, the method also includes processing the first medical image to obtain plural processed images, wherein each of the plural processed images has a corresponding image resolution; applying the plural processed images to respective multi-training artificial neural networks (MTANNs) to obtain plural output images, wherein each MTANN is trained to detect the anatomical structure at one of the corresponding image resolutions; and combining the plural output images to obtain a second medical image in which the appearance of the anatomical structure is enhanced.
Owner:UNIVERSITY OF CHICAGO

Faster R-CNN pulmonary tuberculosis symptom detection system and method based on FPN

InactiveCN110175993AImprove accuracyReduce the risk of delaying treatmentImage enhancementImage analysisMedicineX-ray
The invention discloses an automatic pulmonary tuberculosis detection system on an X-ray chest radiograph based on a characteristic pyramid network (FPN). An X-ray chest radiograph of pulmonary tuberculosis is marked; a Faster R-CNN network learning module with an FPN as the rear end is adopted for training and learning, pulmonary tuberculosis lesion symptoms are mastered, and the automatic diagnosis and detection capacity of the pulmonary tuberculosis lesion symptoms is obtained, so that the automatic detection, positioning and probability prediction of the pulmonary tuberculosis lesion are achieved, and a final pulmonary tuberculosis detection result is obtained. The FPN serves as the rear end of the detection network, the semantic features in a multi-scale network layer can be better combined, each layer is independently predicted, and fusion is finally carried out, so that focuses of different scales can be better detected. Based on a recognition technology of the deep learning network to the digital image, the automatic detection, positioning and probability prediction of the tuberculosis focus are realized, the accuracy of the focus detection is improved, and the risk of thedelayed treatment of a tuberculosis patient is reduced.
Owner:THE FIRST AFFILIATED HOSPITAL OF MEDICAL COLLEGE OF XIAN JIAOTONG UNIV

X-ray chest radiograph bone suppression processing method based on wavelet decomposition and convolutional neural network

The invention discloses an X-ray chest radiograph bone suppression processing method based on wavelet decomposition and a convolutional neural network. By adopting a convolutional neural network structure and using a chest radiograph image wavelet coefficient as the input, a wavelet coefficient image of a corresponding bone image or soft tissue image is predicted. The existing bone image or soft tissue image artificial neural network prediction method processes an original chest radiograph image by adopting a relatively complex contrast normalization method, whereas this method processes the input chest radiograph image in a wavelet domain, and can normalize the amplitude by adopting a simple method; and the existing bone image or soft tissue image artificial neural network prediction method needs to design an image feature extraction method as the input of the artificial neural network, whereas this method completes an image feature extraction process by directly using the wavelet decomposition image of the chest radiograph image as an input, training the convolutional neural network to learn automatically and optimizing the convolution kernel, so the image feature extraction method does not need to be designed.
Owner:SOUTHERN MEDICAL UNIVERSITY

Lung tissue image segmentation method based on deep learning

InactiveCN110310289AResolve local convergenceSolve the problem of false positive segmentationImage enhancementImage analysisData setX-ray
The invention provides a lung tissue image segmentation method based on deep learning, and belongs to the technical field of medical image segmentation. The lung tissue image segmentation method comprises the steps that an X-ray chest radiograph image is input into a segmentation model, the segmentation model is obtained through training of multiple sets of training data, and each set of trainingdata in the multiple sets of training data comprises the X-ray chest radiograph image and a corresponding gold standard used for identifying lung tissue; and output information of the model is obtained, and the output information comprises a segmentation result of the lung tissue in the X-ray chest radiography image. According to the lung tissue image segmentation method, the segmentation of the lung tissue of the X-ray chest radiography is realized through an improved Deeplabv3+ deep learning method, and the problems of local convergence and false positive segmentation when the lung tissue issegmented by using a traditional method are solved; the lung tissue image segmentation method respectively obtains 95.3% of MIoU and 94.8% of MIoU on the public data set and the pneumoconiosis data set; and the false positive problem of the FCN network is solved, and the segmentation accuracy of ribs at the thoracic diaphragm angle and on the X-ray chest radiography in the SCAN network method isimproved.
Owner:BEIJING JIAOTONG UNIV

Small cell lung carcinoma biomarker panel

The invention relates generally to the field of cancer detection, diagnosis, subtyping, staging, prognosis, treatment and prevention. More particularly, the present invention relates to methods for the detection, and / or diagnosing and / or subtyping and / or staging of lung cancer in a patient. Based on a particular panel of biomarkers, the present invention provides methods to detect, diagnose at an early stage and / or differentiate small cell lung cancer (SCLC) from non-small cell lung cancer (NSCLC) and within NSCLC to differentiate between squamous cell carcinomas (SCC), adenocarcinomas (AC), within SCC to discriminate G2 and G3 stage and within lung cancer to differentiate for lung cancers with or without neuroendocrine origin. It further provides the use of said panel of biomarkers in monitoring disease progression in a patient, including both in vitro and in vivo imaging techniques. The in vitro imaging techniques typically include an immunoassay detecting protein or antibody of the biomarkers on a sample taken from said patient, e.g. serum or tissue sample. The in vivo imaging techniques typically include chest radiographs (X-rays), Computed Tomography (CT) imaging, spiral CT, Positron Emission Tomography (PET), PET-CT and scintigraphy for molecular imaging and diagnosis and to monitor disease progression and treatment response in patients. It is accordingly a further aspect to provide a kit to perform the aforementioned diagnosing and / or subtyping and / or staging assay and the imaging techniques, comprising reagents to determine the gene expression or protein level of the aforementioned panel of biomarkers for in vitro and in vivo applications.
Owner:MUBIO PRODS BV

Small cell lung carcinoma biomarker panel

The invention relates generally to the field of cancer detection, diagnosis, subtyping, staging, prognosis, treatment and prevention. More particularly, the present invention relates to methods for the detection, and / or diagnosing and / or subtyping and / or staging of lung cancer in a patient. Based on a particular panel of biomarkers, the present invention provides methods to detect, diagnose at an early stage and / or differentiate small cell lung cancer (SCLC) from non-small cell lung cancer (NSCLC) and within NSCLC to differentiate between squamous cell carcinomas (SCC), adenocarcinomas (AC), within SCC to discriminate G2 and G3 stage and within lung cancer to differentiate for lung cancers with or without neuroendocrine origin. It further provides the use of said panel of biomarkers in monitoring disease progression in a patient, including both in vitro and in vivo imaging techniques. The in vitro imaging techniques typically include an immunoassay detecting protein or antibody of the biomarkers on a sample taken from said patient, e.g. serum or tissue sample. The in vivo imaging techniques typically include chest radiographs (X-rays), Computed Tomography (CT) imaging, spiral CT, Positron Emission Tomography (PET), PET-CT and scintigraphy for molecular imaging and diagnosis and to monitor disease progression and treatment response in patients. It is accordingly a further aspect to provide a kit to perform the aforementioned diagnosing and / or subtyping and / or staging assay and the imaging techniques, comprising reagents to determine the gene expression or protein level of the aforementioned panel of biomarkers for in vitro and in vivo applications.
Owner:MUBIO PRODS BV

Pulmonary tuberculosis intelligent recognition method and system with image symptom interpretation

ActiveCN110969613AReliable Activity JudgmentReliable inner relationshipImage enhancementImage analysisX-rayImaging study
The embodiment of the invention provides a pulmonary tuberculosis intelligent recognition method and system with image symptom interpretation. The pulmonary tuberculosis intelligent recognition methodcomprises the steps: preprocessing an X ray chest radiograph so as to be converted into a vector diagram; carrying out abnormal region identification to obtain a classification result of whether a suspected focus exists or not; judging whether a suspected focus is identified in the abnormal area or not; performing classification correction processing to obtain a conditional probability of the suspected lesion; judging whether a suspected focus caused by pulmonary tuberculosis exists in the abnormal area or not; processing a suspected area corresponding to the suspected focus on an original image to obtain a sub-image vector diagram; explaining that the abnormal region has image characterization significance to obtain characterization description to judge whether the abnormal region has pulmonary tuberculosis or not; and based on the eigenimage description, carrying out pulmonary tuberculosis activity discrimination. According to the embodiment of the invention, the internal relation between the image symptom features in the chest radiography can be effectively obtained, and the judgment logic of iconography can be better met compared with the judgment made only based on the image,and the recognition precision and efficiency can be greatly improved.
Owner:PERCEPTION VISION MEDICAL TECH CO LTD +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products